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Abstract Visceral fat has been associated with multiple
cardiovascular disease (CVD) risk factors. The aim of this
study was to identify anthropometrical measures most
closely associated with some well-known CVD risk factors.
Because most Asians at risk have normal body mass index
(BMI) according to Western standards, we studied healthy
nonobese Korean males (n 
 

 
 102; age: 36.5 
 

 
 0.8 years,
BMI: 23.8 
 

 
 0.2 kg/m
 
2
 
). Visceral fat area (VFA) at the
fourth lumbar vertebra was associated with increased post-
prandial triglyceride (TG) response (
 
r
 
 
 

 
 0.53, 
 
P
 
 
 

 
 0.001)
and with plasma malondialdehyde (MDA) (
 
r
 
 
 

 
 0.36, 
 
P
 
 
 

 
0.01) and PGF2
 

 
 (
 
r
 
 
 

 
 0.24, 
 
P
 
 
 

 
 0.05). When matched for
BMI and age, men with high VFA (HVFA) (
 

 
100 cm
 
2
 
; n 
 

 
27) had higher blood pressure (
 
P
 
 
 

 
 0.01), increased con-
sumption of cigarettes (
 
P
 
 
 

 
 0.01), and lower ratio of energy
expenditure to calorie intake (
 
P
 
 
 

 
 0.01) as compared with
low VFA men (
 

 
100 cm
 
2
 
; n 
 

 
 27). Men with HVFA showed
higher TG, glucose, and insulin responses following fat and
oral glucose tolerance tests respectively higher plasma con-
centrations of MDA (
 
P
 
 
 

 
 0.001), urinary PGF
 
2
 

 
 (
 
P
 
 
 

 
 0.05),
and lymphocytes deoxyribonucleic acid tail moments (
 
P
 
 
 

 
0.01). Conversely, HVFA was associated with lower testos-
terone, insulin-like growth factor-1, and brachial artery flow-
mediated dilation (
 
P
 
 
 

 
 0.001).  In conclusion, our data in-
dicate that visceral fat accumulation, even in nonobese
men, is a major factor contributing to increased CVD
risk.
 
—Jang, Y., O. Y. Kim, H. J. Ryu, J. Y. Kim, S. H. Song, J. M.
Ordovas, and J. H. Lee. 
 
Visceral fat accumulation deter-
mines postprandial lipemic response, lipid peroxidation,
DNA damage, and endothelial dysfunction in nonobese Ko-
rean men. 
 
J. Lipid Res.
 
 2003. 
 
44:
 
 2356–2364.
 
Supplementary key words
 
flow-mediated dilation 
 
•
 
 body fat distribu-
tion 
 
•
 
 glucose tolerance
 
The most recent figures about the epidemic of obesity
and overweight in the US and other industrialized coun-
tries are appalling. Thirty-four percent of US adults are
considered overweight, and an additional 31 percent are
obese. The consequences of this are far beyond the esthet-
ics of the population. Being overweight or obese increases
the risk of hypertension, heart disease, stroke, diabetes,
and some cancers. In the US alone, 300,000 people die
each year due to obesity-related causes, making it the sec-
ond-leading cause of death after smoking. Asians experi-
ence similar risk of obesity-related diseases, but the prob-
lem is more insidious, as the risk threshold at which body
mass index (BMI) appears to trigger the disease may be
much lower for Asians (
 

 
23 kg/m
 
2
 
) than for white popu-
lations (30 kg/m
 
2
 
) (1). This may result from differences
in body frame that affect the relation between body fat
and BMI.
The population of Korea, similar to other industrialized
countries in Asia, is experiencing dramatic and fast changes
in dietary and physical activity habits that are the driving
force behind the increase in obesity and obesity-related
diseases. Korean adults have increased the percent of calo-
ries from fat in their diets from 6% in 1969 to 19% in
1998. Despite the greater than 3-fold increase in the di-
etary fat intake, their daily calorie intake (about 1,950
kcal/d) and BMI (about 22.5 kg/m
 
2
 
) have changed little
over the same period (2). However, these lifestyle changes
have dramatically affected the central adipose tissue distri-
bution pattern as reflected by the global increase of waist-
hip ratio (WHR). Among Koreans, the mortality rate (per
100,000 of the population) as a result of ischemic heart
disease has rapidly increased from 6.8 in 1988 to 13.8 in
 
1
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1997 (3). The increase in cardiovascular disease (CVD)
rates is partially related to the rapid increase in the num-
ber of elderly subjects; however, the increase of fat intake
in Korean parallels also the disease trends (2, 3). These
temporal changes suggest that the increase in fat intake
and central fat distribution may be partially responsible
for the increasing CVD rates in Korea and other neighbor-
ing countries.
Previous research has shown that adipose tissue distribu-
tion is more closely associated with risk of diabetes, hyper-
tension, and hyperlipidemia than total body fat or BMI
(4). Thus, visceral fat values above 100–130 cm
 
2
 
 represent
a strong risk for these metabolic disturbances (5, 6). More-
over, both obesity and visceral fat accumulation have been
reported to be related with increased postprandial lipemia
(7), an underestimated CVD risk factor. However, it re-
mains uncertain which measure of obesity represents the
best predictor of postprandial lipemia response. Moreover,
other behavioral factors, such as alcohol consumption, cig-
arette smoking, or poor eating patterns such as excessive
calorie or high fat intake, are also significant determinants
of postprandial lipemia, as well as lipid peroxidation, and
deoxyribonucleic acid (DNA) damage (8–13).
The objectives of this study were to identify the anthro-
pometrical factor most closely associated with variability
on the postprandial lipid response to a fat load challenge
and to investigate the relationships between this variabil-
ity, lipid peroxides, and DNA damage of lymphocytes in
groups of healthy nonobese men categorized according to
the relevant anthropometrical factor emerging from our
research. Our findings will contribute to a better under-
standing of the metabolic alterations and behavioral fac-
tors responsible for the rapid increase in CVD mortality in
Korea and to provide guidance for preventive and thera-
peutic interventions.
METHODS
 
Subjects
 
Study subjects were recruited from volunteers who responded
to advertisements for a nutrition study conducted by the Clinical
Nutrition Research Team at Yonsei University in 2001. All sub-
jects had normal glucose tolerance tests and electrocardiograms.
None of them was taking any medication or had clinical evidence
of CVD or cancer. Finally, 102 healthy men were selected as study
subjects. The ranges for age and BMI were 21–53 years and 18.2–
27.6 kg/m
 
2
 
, respectively. Written informed consent was obtained
from all subjects and the protocol was approved from the Ethical
Committee of the Yonsei University.
 
Meal tolerance test
 
A 6 h postprandial lipemia response test was carried out start-
ing at 8:30 AM after an overnight fast of greater than 12 h. A
standardized test meal was prepared in the metabolic ward using
common food items. It consisted of a sandwich containing white
bread, lettuce, ham, and soybean oil-based mayonnaise. The en-
ergy content, calculated from the computerized database Korean
food-code based on food composition tables from the National
Rural Living Science Institute (6th edition, 2000) in Korea, was
608 kcal (2.54 mJ), representing the average calorie intake from
a traditional breakfast. Fat represented 41.4% (28 g) of the calo-
ries, carbohydrates made up 45.4% (69 g), and 13.2% of calories
(20 g) were derived from protein. In contrast, the macronutrient
composition of the subjects’ usual diet was that of a typical diet
with cooked refined rice, consumed by a substantial number of
Koreans, that is, about 57% of energy from carbohydrate, 22% from
fat, 16% from protein, and 5% from others (mainly alcohol).
 
Anthropometrical and blood pressure measurements
 
Body weight and height were measured in the morning, un-
clothed and without shoes. BMI was calculated as body weight in
kilograms divided by height in square meters. Waist and hip cir-
cumferences were combined into the WHR representing a com-
monly used surrogate of body fat distribution. Blood pressure
was read from the left arm while subjects remained seated. An av-
erage of three measurements was recorded for each subject.
 
Regional fat and muscle areas
 
We performed computerized tomography (CT) scanning us-
ing a General Electric (GE) High Speed Advantage 9800 scanner
(Milwaukee, WI) to measure fat and muscle areas. Four cross-sec-
tional images were obtained from each subject. Two abdominal
ones at the level of the first lumbar (L1) and fourth lumbar (L4)
vertebras, one from the thigh (midway between patella and pu-
bis), and one from the calf (at the most protruding area). Each
CT slice was analyzed for the cross-sectional area of fat using a
density control program available in the standard GE computer
software. Parameters for total abdominal fat density at the levels
of L1 and L4 were selected between the range of 
 

 
150 and 
 

 
50
Hounsfield units (HU). Total abdominal fat area was divided
into visceral and subcutaneous fat areas to calculate specific fat
areas. Parameters for thigh and calf muscle areas were selected
as between the range of 
 

 
49 and 
 

 
100 HU and for fat areas be-
tween 
 

 
150 and 
 

 
50 HU.
 
Blood collection
 
Venous blood samples were obtained from the forearm and
collected into EDTA-treated and plain tubes during fasting
(baseline), and at 2 h, 3 h, 4 h, and 6 h after breakfast for assess-
ment of glucose, insulin, free fatty acids (FFAs), and triglycerides
(TGs). Tubes were immediately covered with aluminum foil and
placed on ice until they arrived at the analytical laboratory
(within 1–3 h) and were stored at 
 

 
70
 

 
C. Subjects were asked to
refrain from performing strenuous exercise or drinking alco-
holic beverages 24 h prior to the fat tolerance test. They were
also instructed to avoid eating or drinking anything except water
during the test period.
 
Serum lipid profile and apolipoprotein A-I and B
 
Fasting serum concentrations of total cholesterol and TG were
measured using commercially available kits on a Hitachi 7150
Autoanalyzer (Hitachi Ltd., Tokyo, Japan). After precipitation of
serum chylomicron, LDL, and VLDL with dextran sulfate-magne-
sium, HDL left in the supernatant was measured by an enzymatic
method. LDL cholesterol concentrations were estimated indi-
rectly using the Friedwald formula for subjects with serum TG 
 

 
4.52 mmol/l (400 mg/ml), or otherwise directly using commer-
cially available kits on a Hitachi 7150 Autoanalyzer. Serum apoli-
poprotein A-I (apoA-I) and apoB were determined by turbidom-
etry at 340 nm using a specific anti-serum (Roche, Switzerland).
 
Oral glucose tolerance test and homeostasis
model assessment
 
At a different time than the fat tolerance test, we carried out a
glucose load test in order to investigate glucose tolerance. Each
subject received a 75 g glucose solution after an overnight fast.
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Venous specimens were collected before and 30 min, 60 min, 90
min, and 120 min after the glucose load test. We used criteria,
newly developed and modified by the National Diabetes Data
Group and the World Health Organization Expert Committee
on Diabetes Mellitus, to categorize subjects according to their
glucose status (14). Glucose was measured by a glucose oxidase
method using the Beckman Glucose Analyzer (Beckman Instru-
ments, Irvine, CA). Insulin was measured by radioimmuno assays
with commercial kits from Immuno Nucleo Corporation (Still-
water, MN). FFA was analyzed with a Hitachi 7150 autoanalyzer
(Hitachi Ltd., Tokyo, Japan). Each response of glucose, insulin,
and FFA was calculated with the area under each response curve.
Insulin resistance (IR) was also calculated with the homeostasis
model assessment (HOMA) (15) using the following equation:
IR 
 

 
 [fasting insulin (
 

 
U/ml) 
 
	
 
 fasting glucose (mmol/l)]/22.5.
 
Other measurements
 
Immunoradiometric assays (IRMAs) were used to measure se-
rum total testosterone using RIA-mat 280 (Byk-Sangtec Diagnos-
tica, Germany) with Cost-A-Count total testosterone. Serum insu-
lin like growth factor-1 (IGF-1) was measured using the IRMA kit
from Diagnostic System Laboratories. Serum leptin was mea-
sured using Packard Cobra II 5005 R-Counter with the human
leptin RIA kit from Linco.
 
Urine collection and 8-epi-prostaglandin F
 
2
 

 
 and
plasma malondialdehyde
 
Urine was collected after a 12 h fast in polyethylene bottles
containing 1% butylated hydroxytoluene before blood collec-
tion. The tubes were immediately covered with aluminum foil
and stored at 
 

 
70
 

 
C until extraction. Urinary 8-epi-prostaglan-
din F
 
2
 


 
 (8-epi-PGF
 
2
 


 
) was quantified with gas chromatography
(Hewlett Packard 6890, Wilmington, DE) and mass selective
detector (Hewlett Packard 3973), according to the modified
method of Pratico, Lawson, and Fitzgerald (16) and Mori et al.
(17). Urinary creatinines were determined by the alkaline pi-
crated (Jeffe) reaction (18), and urinary 8-epi-PGF
 
2
 


 
 levels were
expressed as picogram per milligram creatinine (pgl/mg of cre-
atinine). Plasma malondialdehyde (MDA) was assayed according
to the fluorometric method described by Buckingham (19).
 
Alkaline comet assay for DNA damage
 
For the comet assay, 120 
 

 
l whole blood was mixed with 900 
 

 
l
PBS and poured gently over 150 
 

 
l lymphocyte separation solu-
tion (HISTOPAQUE-1077). After centrifugation at 1,450 rpm for
4 min, lymphocytes were pipetted out and transferred to another
tube. DNA damage was analyzed basically as described by Green
et al. (20). All steps were performed under dimmed light and the
electrophoresis tank was covered with black paper to avoid addi-
tional light-induced DNA damage.
 
Vasodilatation response of brachial artery
 
Using high-resolution ultrasound (GE Vigmed Ultrasound,
Horten, Norway), we assessed brachial arterial vasoreactivity to
reactive hyperemia (flow-mediated dilation; FMD) and sublin-
gual nitroglycerin (nitroglycerin-mediated dilation; NMD) with
the method described by Kang et al. (21). A 10 MHz linear
phased array ultrasound transducer (GE Vigmed Ultrasound,
Horten, Norway) was used to image the dominant arm branchial
artery longitudinally 3–5 cm just above the antecubital fossa. All
subjects rested in the supine position for 10 min in a quiet room.
The straight segment of the artery was chosen. After the depth
and gain setting were optimized to identify the vessel wall, lumen
interface and baseline brachial artery diameter were obtained.
Brachial artery diameter was measured from the anterior to the
posterior interface between the media and the adventitia and de-
termined at end diastole on 2D image. Reactive hyperemia was
induced by inflation and then deflation of a pneumatic cuff
placed around the forearm portion. The blood pressure cuff was
inflated to 250 mm Hg for 5 min, creating distal limb ischemia.
After release of the cuff, brachial artery diameter was measured
within the first 15 s of reactive hyperemia. FMD was then used as
a measure of endothelium-dependent vasodilation. The brachial
artery was allowed to return to the initial baseline level 10 min af-
ter cuff release. A further baseline brachial artery diameter was
obtained. A 0.6 mg of nitroglycerin was then given sublingually,
and the brachial artery diameter was then measured for the en-
suing 3 min. The NMD was used as a measure of endothelium-
independent vasodilation. The percent change in diameter caused
by reactive hyperemia was calculated by dividing the difference
from baseline end-diastolic diameter by the baseline value
(FMD%). The percent change in diameter caused by nitroglyc-
erin administration was also calculated in the same way (NMD%).
Blood pressure and heart rate were measured before the exami-
nation. All data were calculated as an average from four consecu-
tive cardiac cycles.
 
Assessment of food intake and physical activity level
 
Usual food intake was assessed with a 24 h recall method and a
semi-quantitative food frequency questionnaire. Nutrient intake
data were calculated as mean values from the same data base as
referred above. Total calorie expenditure (kcal/day) was calcu-
lated from activity patterns including basal metabolic rate, physi-
cal activity for 24 h (22), and specific dynamic action of food.
Basal metabolic rate for each subject was calculated with the Har-
ris-Benedict equation (23).
 
Statistical analysis
 
We used SPSS version 11.0 for Windows (Statistical Package
for the Social Science, SPSS Inc., Chicago, IL) for all our statisti-
cal analyses. Each variable was examined for normal distribution
and significantly skewed variables were log transformed. For de-
scriptive purposes, mean values were presented on untransformed
and unadjusted variables. Results were expressed as mean 
 

 
 SE.
We used Pearson correlation coefficient to evaluate the correla-
tion of the variables, and multiple regression analysis to investi-
gate main factors influencing postprandial lipid response.
Following identification of the main factor, subjects in upper
25th percentile of the factor were selected and individually
matched by age (within a 2 year difference) and BMI (within a
1 kg/m
 
2
 
 difference) to subjects within the remaining 75th per-
centile. Selected subjects were grouped for subsequent analyses.
Chi-squared tests were used to compare differences in frequen-
cies for categorical variables. A two tailed value of 
 
P
 
 
 

 
 0.05 was
considered statistically significant.
 
RESULTS
 
Basal anthropometrical, clinical, and behavioral
characteristics of the participants
Table 1
 
 shows the basal characteristics of the 102 sub-
jects initially selected to participate in this study. Their
mean BMI was 23.8 
 

 
 0.21 with a range of 18.2 to 27.6
years. Seventy-four men reported consumption of alco-
holic beverages and 39 were current smokers. These sub-
jects had similar habitual dietary fat intake, physical activ-
ity, and socioeconomic status.
 at Yonsei University M
edical Library, on July 21, 2014
w
w
w
.jlr.org
D
ow
nloaded from
 
 Jang et al.
 
Visceral fat, postprandial lipemia, and lipid peroxidation 2359
 
Relationship of anthropometrical parameters to
postprandial lipemia and lipid peroxidation
 
The average mean values of subcutaneous and visceral
fat areas (VFAs) at L1 and L4 vertebrae, postprandial TG
area, MDA, and 8-epi-PGF
 
2
 


 
 of the 102 subjects are shown
in Table 1. 
 
Table 2
 
 shows that some anthropometrical pa-
rameters such as body fatness and abdominal adipose tis-
sue distribution (WHR and VFA at L1 and L4 vertebrae)
were positively correlated with postprandial lipemia,
whereas all variables reflecting body fatness and adipose
tissue distribution were positively associated with plasma
MDA concentrations. BMI, WHR, subcutaneous fat areas
at L1 and L4 levels, and VFA at L4 showed positive correla-
tion with urinary excretion of 8-epi-PGF
 
2
 


 
. Postprandial
lipemia showed positively significant correlation with
plasma MDA concentration (
 
R
 
 
 

 
 0.332, 
 
P
 
 
 

 
 0.005, data
was not shown in Table 2). Age was associated with neither
postprandial lipemia nor lipid peroxides.
 
Identification of main influencing factor on postprandial 
lipid response
 
Based on the information generated from the correla-
tion analyses between body fat measures and postprandial
TG area, we carried out stepwise multiple regression anal-
ysis in order to identify the most significant anthropomet-
rical predictor of postprandial lipid response. Measures of
body fatness, alcohol consumption, and cigarette smok-
ing were used as independent variables, and postprandial
TG area was the dependent variable. The data presented
in 
 
Table 3
 
 show that the most significant predictor of post-
prandial lipemic response was VFA at L4 level followed by
total fat area at L4 level.
 
Comparison of postprandial lipemia, lipid peroxidation, 
DNA damage, and endothelial cell function between the 
two groups categorized according to VFA at L4 level
Figure 1
 
 shows the distribution of VFA at L4 level in all
102 nonobese healthy men. Subjects in upper 25th per-
centile of the main factor (VFA at L4 level) were catego-
rized as high VFA (HVFA, n 
 

 
 27). The lowest VFA in this
group was over 100 cm
 
2
 
 (100.3 cm
 
2
 
) and the average area
was 114 
 

 
 2 cm
 
2
 
. Subjects with HVFA were age- (within a 1
year difference) and BMI- (within a 1 kg/m
 
2 difference)
matched to control subjects selected for having low VFA
(LVFA; 100 cm2, n  27). The average area of the con-
trol group was 74  3 cm2.
Blood pressure and body fat distribution
Men within the HVFA were characterized by higher
WHR and blood pressure and higher consumption of cig-
arettes than those within the LVFA group (Table 4).
Among subjects within the HVFA, 38.5% had hyperten-
sion. No differences were found in subcutaneous fat area
at both L1 and L4 vertebrae (Table 4). Nonobese men
with HVFA showed higher ratio of visceral to subcutane-
TABLE 1. General characteristics of the sample of 102 nonobese 
healthy men
Min–Max
Age (years) 36.5  0.82 (21–53)
BMI (kg/m2) 23.8  0.21 (18.2–27.6)
WHR 0.86  0.00 (0.75–0.97)
Body fat (%) 23.5  0.56 (11.0–38.0)
Blood pressure
SBP (mmHg) 123.2  1.30 (102–171)
DBP (mmHg) 77.0  1.09 (55–119)
Current smoking (%) 38
Tobacco consumption
(cigarettes/day)
7.90  0.95 (0–40)
Current drinking (%) 72
Alcohol intake (g/day) 18.6  2.48 (0.0–153.9)
Hypertension (%) 16
Total energy expenditure (kcal/day) 2465.8  36.7 (1862–2943)
Total calorie intake (kcal/day) 2402.8  51.7 (1112–3104)
% fat from total calorie intake 21.9  0.88 (11.9–33.8)
Adipose tissue areas (cm2) at first 
lumbar vertebra
Subcutaneous 72.1  3.23 (12.8–182.7)
Visceral 98.7  4.89 (13.3–227.0)
Adipose tissue areas (cm2) at fourth
lumbar vertebra
Subcutaneous 76.2  2.92 (17.3–139.4)
Visceral 126.2  4.47 (44.4–266.6)
Postprandial TG area 972.4  59.0 (225–3174)
MDA (nmol/ml) 3.11  0.17 (0.40–7.31)
8-epi-PGF2
 (pg/mg creatinine) 251.8  24.0 (20.2–1156.4)
BMI, body mass index; DBP, diastolic blood pressure; 8-epi-PGF2
,
8-epi prostaglandin F2
; MDA, malondialdehyde; SBP, systolic blood
pressure; TG, triacylglycerol; WHR, waist-hip ratio. Mean  SE.
TABLE 2. Pearson correlations of age, body fat distribution, total 
triglyceride response area, and lipid peroxides in 102 nonobese 
healthy men
Postprandial
TG Areaa MDA 8-epi-PGF2
a
R P R P R P
Age 0.166 0.138 0.032 0.771 0.102 0.348
SBP 0.421 0.000 0.264 0.015 0.160 0.138
DBP 0.424 0.000 0.244 0.021 0.115 0.289
BMI 0.197 0.078 0.308 0.004 0.248 0.021
WHR 0.346 0.002 0.292 0.007 0.243 0.023
L1VF 0.461 0.000 0.327 0.002 0.201 0.064
L1SF 0.083 0.464 0.321 0.003 0.414 0.000
L4VF 0.586 0.000 0.356 0.001 0.242 0.025
L4SF 0.036 0.754 0.315 0.003 0.359 0.001
L1VF, visceral fat area at first lumbar vertebra; L1SF, subcutaneous
fat area at first lumbar vertebra; L4VF, visceral fat area at fourth lumbar
vertebra; L4SF, subcutaneous fat area at fourth lumbar vertebra.
a LN, log transformed.
TABLE 3. Stepwise multiple regression for 102 nonobese healthy 
men using age, blood pressure, anthropometric parameter, fat areas at
different levels of body, alcohol consumption, and cigarette smoking as 
independent variables and postprandial TG area as dependent variable
Dependent Variable Step
Independent 
Variable R2
Adjusted 
R2 P
Postprandial TG areaa 1 step L4VF 0.344 0.336 0.000
2 step L4TF 0.396 0.381 0.000
L4TF, total fat area at 4th lumbar vertebra. Fat areas at different
levels of body: total, visceral, and subcutaneous fat areas at both 1st and
4th lumbar vertebra.
a LN, log transformed.
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ous fat area and lower muscle area of midthigh compared
with those with LVFA.
Serum lipid, hormone, and oral glucose tolerance test
No differences were found in HDL cholesterol and
apoA-I; however, men characterized by a HVFA showed
higher serum concentrations of TG, total cholesterol,
LDL cholesterol, and apoB (Table 5). Moreover, they had
lower serum concentrations of testosterone and IGF-1 and
higher fasting FFA levels than those with LVFA. Oral glu-
cose tolerance test (OGTT) area under the curve for glu-
cose, insulin, and FFA were higher in nonobese men with
HVFA than in those with LVFA (Table 5).
Lipid peroxides, DNA damage in lymphocytes, and
vasoreactivity of brachial artery
Nonobese men with HVFA showed higher concentra-
tions of urinary excretion of PGF2
 and plasma MDA than
those with LVFA (Fig. 2). Tail moments on the DNA in
lymphocytes were also significantly higher in nonobese
men with HVFA as compared with those in the LVFA
group (Fig. 2). In brachial artery diameters at baseline to
test for FMD% and NMD%, there were no significant dif-
ferences between LVFA group and HVFA group (for
FMD%; 4.46  0.13 mm vs. 4.72  0.14 mm, P  0.177,
and for NMD%: 4.48  0.13 mm vs. 4.67  0.14 mm, P 
0.678). Both groups had no significant differences in
NMD% (LVFA group: 15.5  1.8%; and LVFA group: 16.5 
1.7%); however, the HVFA group had significantly lower
FMD% compared with the LVFA group (Fig. 2).
Postprandial responses of TG, glucose, FFA, and insulin
Figure 3 illustrates concentrations of TG, glucose, FFA,
and insulin before and after the mixed-meal tolerance test
among subjects with HFVA and LVFA. Subjects within the
HVFA showed higher concentrations of TG at the 0 h, 2 h,
3 h, 4 h, and 6 h time points and 82% greater TG AUC
compared with men in the LVFA group. TG concentra-
TABLE 4. General characteristics, fat, and muscle areas in two 
groups of nonobese men matched on the basis of age and BMI
but with low versus high visceral fat area
Low VFA HVFA 
Age (years) 40.2  1.71 40.1  1.07
BMI (kg/m2) 25.2  0.25 25.3  0.30
Waist-hip ratio 0.86  0.01 0.91  0.01c
Body fat (%) 24.1  0.87 26.0  0.80
Blood pressure
SBP (mmHg) 122.7  1.94 132.7  2.79b
DBP (mmHg) 75.0  1.78 85.3  2.23c
Current drinking (%) 75.0 88.9
Alcohol (g/day) 17.1  5.49 25.2  5.11
Current smoking (%) 39.3 70.4a 
Tobacco (cigarettes/day) 3.50  1.08 13.4  2.02b
Hypertension (%) 10.7 38.5a
First lumbar vertebra
Total fat (cm2) 177.6  8.68 237.0  10.5b
Visceral fat (cm2) 102.6  5.92 149.8  7.57b
Subcutaneous fat (cm2) 75.1  4.06 87.2  5.92
Visceral-subcutaneous fat ratio 1.40  0.08 1.87  0.14a
Fourth lumbar vertebra
Total fat (cm2) 209.6  7.83 259.8  8.30b
Visceral fat (cm2) 73.7  3.03 114.1  2.03b
Subcutaneous fat (cm2) 135.8  6.60 146.6  7.86
Visceral-subcutaneous fat ratio 0.57  0.03 0.83  0.04b
Calf
Fat (cm2) 16.3  0.49 16.2  0.80
Muscle (cm2) 82.8  2.20 80.1  3.25
Mid thigh
Fat (cm2) 44.3  2.19 43.0  2.44
Muscle (cm2) 159.0  1.78 147.7  2.66b
HVFA, high visceral fat area (VFA  100 cm2, n  27); VFA, vis-
ceral fat area. Low VFA, VFA  100 cm2, n  27. Mean  SE.
a P  0.05 compared with low VFA.
b P  0.01 compared with low VFA.
c P  0.001 compared with low VFA.
Fig. 1. Distribution of visceral fat area (VFA) at 4th lumbar verte-
bra in 102 nonobese healthy men.
TABLE 5. Serum lipids, hormones, and glucose and responses to
a 75 g oral glucose tolerance test in two subgroups of nonobese
men matched on the basis of age and BMI but with low versus
high visceral fat area
Low VFA HVFA
TG (mg/dl) 148.2  16.0 233.4  22.6a
Total cholesterol (mg/dl) 192.2  6.22 229.4  7.29b
HDL cholesterol (mg/dl) 49.2  2.30 45.5  1.71
LDL cholesterol (mg/dl) 113.7  5.28 137.7  7.47c
Total/HDL cholesterol 4.08  0.19 5.21  0.23b
ApoA-I (mg/dl) 131.9  4.50 127.9  4.01
ApoB (mg/dl) 84.8  2.82 105.7  4.17b
Testosterone (ng/ml) 6.22  0.23 5.33  0.22a
IGF-1 (ng/ml) 289.2  22.1 230.9  10.3c
Leptin (ng/ml) 3.33  0.26 3.94  0.50
Fasting level
Glucose (mg/dl) 83.0  1.46 89.5  2.80d
FFA (Eq/l) 434.7  31.0 559.8  43.8c
Insulin (IU/ml) 8.35  0.76 9.30  0.72
Response area
Glucose (mg/dl 	 h) 226.5  8.16 259.0  9.34a
FFA (Eq/l 	 h) 508.7  43.9 654.4  46.9c
Insulin (IU/l 	 h) 77.9  4.14 107.9  7.24a
HOMA insulin resistance 1.70  0.16 2.09  0.19
Apo, apolipoprotein; FFA, free fatty acid; IGF-1, insulin-like growth
factor-1; HOMA, homeostasis model assessment. n  27. Mean  SE.
a P  0.01 compared with low VFA.
b P  0.001 compared with low VFA.
c P  0.05 compared with low VFA.
d P  0.1 compared with low VFA.
 at Yonsei University M
edical Library, on July 21, 2014
w
w
w
.jlr.org
D
ow
nloaded from
 
Jang et al. Visceral fat, postprandial lipemia, and lipid peroxidation 2361
tions at 6 h were back to fasting values among men with
LVFA; however, among men with HVFA, TG concentra-
tions measured at the 6 h time point remained 14% higher
than fasting values (P  0.032). Glucose and insulin con-
centrations at the 2 h and 3 h time points and fasting FFA
were higher in the HVFA than in the LVFA group. Post-
prandial AUCs for FFA, glucose, and insulin were signifi-
cantly increased by 28%, 14%, and 38%, respectively (Fig.
3), as compared with LVFA group.
Total calorie intake and total energy expenditure
There were no significant differences between the two
groups in the proportion of energy intake derived from
macronutrients and alcohol. However, men with HVFA
showed higher total calorie intake, lower total energy ex-
penditure, and lower ratio of total energy expenditure to
total calorie intake than those with LVFA (Table 6).
Adjusted effects of visceral fat at L4 level on postprandial 
TG area, lipid peroxides, DNA damage, and endothelial 
cell function
The HVFA group had the increased levels of postpran-
dial TG area, MDA, 8-epi-PGF2
, and DNA damage, and
decreased levels of FMD compared with LVFA group (Ta-
ble 7). However, because the significant differences in
smoking status between the LVFA and HVFA groups we
carried the analyses after adjustment for cigarette smok-
ing. The results of these analyses provided a similar pat-
tern to those described for unadjusted results.
DISCUSSION
Our data show that abdominal body fat distribution,
more specifically VFA at the L4 level, an index of meta-
bolic complications in obese subjects (24), was the major
predictor of postprandial lipemia response (measured as
TG AUC) in our population consisting of nonobese sub-
jects. Moreover, we demonstrated tight associations be-
tween HVFA at the L4 level, peroxidation (measured as
urinary 8-epi-PGF2
, plasma MDA, and DNA damage),
and glucose tolerance (measured as glucose, insulin, and
FFA concentrations). Most interestingly, even for subjects
Fig. 2. Lipid peroxides, deoxyribonucleic acid (DNA) damage of
lymphocytes and flow-mediated dilation of brachial artery in two
subgroups of nonobese men matched on the basis of age and body
mass index (BMI) but with low versus high VFA, mean  SE. * P 
0.05, ** P  0.01, *** P  0.01 compared with low VFA subgroup.
Low VFA, VFA  100 cm2; high VFA, VFA  100 cm2; TM, tail mo-
ment  % of DNA in the tail 	 tail length (m). 8-epi-PGF2
, 8-epi-
prostaglandin F2
; FMD, flow-mediated dilator.
Fig. 3. Postprandial responses of triglyceride, glucose, free fatty
acid, and insulin to a high-fat meal in two subgroups of nonobese
men matched on the basis of age and BMI but with low versus high
VFA mean  SE. * P  0.05, ** P  0.001 compared with low VFA
subgroup. Low VFA, VFA  100 cm2; high VFA, VFA  100 cm2.
TABLE 6. Usual total calorie intake and total energy expenditure in 
two subgroups of nonobese men matched based on age and BMI but 
with low versus high visceral fat area
Low VFA HVFA
Total energy expenditure 2555.8  67.4 2364.8  28.5a
Total calorie intake 2391.2  67.5 2541.6  43.7a
% protein 15.8  0.43 16.4  0.77
% carbohydrate 58.2  1.18 54.7  1.56
% fat 21.2  1.14 22.8  1.37
% alcohol 4.83  0.57 6.10  0.75
Total energy expenditure/
total calorie intake 1.06  0.04 0.93  0.01b
Mean  SE.
a P  0.05 compared with low VFA.
b P  0.01 compared with low VFA.
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with normal BMI, HVFA was associated with unhealthy life-
style factors such as higher consumption of cigarettes and
lower ratio of total energy expenditure to total calorie in-
take compared with subjects with LVFA.
Metabolic abnormalities, such as high blood pressure,
high lipid concentrations, and increased areas of glucose,
FFA, and insulin following an OGTT, in subjects with high
visceral fat are consistent with a “visceral fat syndrome”
proposed by Yamashita et al. (24). As visceral adipose tis-
sue, not subcutaneous adipose tissue is drained by the
portal venous system and has a direct connection with the
liver, the higher lipolytic activity in visceral adipocytes
leads to IR by causing FFA levels to increase in the liver
(25, 26). In glucose metabolism, response areas of glu-
cose, FFA, and insulin were higher in HVFA group com-
pared with LVFA group; however, as HOMAIR was not
significantly different between the two groups, this is
probably due to the fact that changes in fasting glucose
level might interfere with the consistency of fasting insu-
lin levels when fasting insulin level is not high. Therefore,
it might be difficult to show IR with only HOMAIR using
only fasting levels of glucose and insulin (27). In addition
to the altered fasting metabolic profile, comparison of
postprandial lipid and glucose metabolism revealed that
men characterized by high levels of visceral adipose tissue
presented increased responses of TG, insulin, and glucose
after the mixed-meal test. Moreover, glucose intolerance
has been linked to oxidation status or lipid peroxidation
(28). Consistent with this notion, our data show that higher
levels of plasma MDA and urinary excretion of 8-epi-
PGF2
 in subjects with HVFA compared with those with
LVFA. In addition, we have shown that urinary excretion
of 8-epi-PGF2
 and plasma MDA correlate with other more
commonly used adiposity indexes, such as BMI and WHR.
Nevertheless, we found some specific relations between
body fat measures and these two measures of lipid peroxi-
dation that may result from differences in specificity and
sensitivity in assessing lipid peroxidation (29, 30). MDA is
a general indicator of oxidative stress rather than a spe-
cific marker of lipid peroxidation and it is known to vary
in response to the diet (23, 24). Dietary factors such as the
amounts of fat intakes and alcohol even in nonobese sub-
jects, especially when calorie intake is in excess of body
needs, may induce the accumulation of visceral fat (13),
which is characterized by its high lipogenic activity as well
as its accelerated lipolytic activity (24).
Oxidative stress, including lipid peroxidation, can neg-
atively influence the antioxidant system (28, 29) and con-
sequently cause greater DNA damage (31). Evaluation of
DNA damage in lymphocytes has been used as a biologi-
cal marker in the detection, monitoring, and prognosis
of chronic degenerative diseases such as atherosclerosis
(31). Differences in the extent of DNA damage in the
normal population have been reported to not only de-
pend on aging but also depend on eating and smoking
habits (9, 32). In this study, the HVFA fat group had in-
creased cigarette smoking, higher lipid peroxidation, and
consequently with higher tail moment of DNA compared
with subjects included in the LVFA group. However, most
interestingly, even after adjusting for cigarette smoking,
DNA damage and lipid peroxides between the two groups
were still significantly different. This suggests an indepen-
dent association between visceral fat accumulation and
oxidation. Increased oxidative stress is also known to cause
endothelial dysfunction by increased vascular superox-
ide anion production and subsequent decrease in nitric
oxide (NO) bioavailability through superoxide-induced
NO degradation (12). Endothelial dysfunction has been
also associated with a range of CVD risk factors includ-
ing smoking (33), visceral fat accumulation indepen-
dent of BMI (34) and subcutaneous fat area (35), and
fasting or postprandial hypertriglyceridemia (11). All of
these risk factors were observed in our nonobese men
with HVFA.
There is substantial evidence supporting a correlation
between visceral fat accumulation and endocrine abnor-
malities including low concentrations of testosterone and
IGF-1 (4, 36, 37). Generally, serum concentrations of tes-
tosterone have a negative correlation with visceral fat
accumulation in men (38–40). Because testosterone de-
creases the lipoprotein lipase activity of visceral fat cells,
it can limit the fat accumulation in visceral region
(38–40). On the other hand, it increases the number of
-adrenergic receptors and the activity of hormone sensi-
tive lipase, accelerating the lypolysis from visceral fat (38–
40). IGF-1 also plays an important role in body fat quantity
and distribution by reducing abdominal VFA, and build-
ing up muscles and bones (34, 35). Serum concentrations
and the activities of testosterone and IGF-1 are inversely
correlated with age, smoking, and visceral fat (37, 39–42).
Accordingly, our study shows that subjects within the
HVFA group had lower levels of testosterone and IGF-1
compared with LVFA group. From this experimental de-
sign, we cannot conclude whether these reduced levels
might cause visceral fat accumulation or, alternatively, vis-
ceral fat accumulation itself might bring a reduction in
testosterone and IGF-1 levels. Serum leptin levels were not
significantly different between the two groups, in agree-
ment with reports showing that leptin levels were related
with total or subcutaneous fat accumulations rather than
with visceral fat accumulation (43, 44).
TABLE 7. Cigarette smoking-adjusted effects of VFA at 4th lumbar 
vertebra on lipid peroxides, deoxyribonucleic acid damage, and
endothelial cell function in two subgroups of nonobese men
matched on the basis of age and BMI but with low versus high VFA
Unadjusted P Adjusted P
Postprandial TG areaa 0.000 0.000
MDA 0.000 0.003
8-epi-PGF2
a 0.011 0.000
DNA damagea 0.000 0.000
FMD 0.000 0.000
Fasting glucosea 0.061 NS
Fasting FFAa 0.044 0.000
Fasting insulin NS NS
HOMA insulin resistancea NS NS
DNA, deoxyribonucleic acid; FMD, flow-mediated dilation; NS, not
significant by ANCOVA.
a LN, log transformed.
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Finally, these nonobese men with HVFA showed posi-
tive energy balance and lower levels of muscle area at
midthigh compared with their low visceral fat counter-
parts, consistent with previous studies showing that body
fat and muscle distribution relate to behavioral habits in-
cluding diet, physical activity, and smoking (36, 45).
In conclusion, we found significant correlations be-
tween abdominal fat distribution, postprandial lipemia,
and lipid peroxidation in nonobese apparently healthy
men. Specifically, our data show that visceral fat accumula-
tion at the L4 level is the most significant correlate of im-
paired postprandial lipid response, lipid peroxidation,
DNA damage of lymphocytes, and endothelial dysfunc-
tion, all of them implicated in cardiovascular morbidity
and mortality risk. The mechanisms behind the relation-
ship between visceral obesity, lipid peroxidation, DNA
damage, and endothelial dysfunction need to be elucidated
in order to implement successful therapeutic approaches.
It has been previously shown that visceral adipose tissue
accumulation at L4 and L5 is positively associated with
C-reactive protein levels, suggesting that the expanded ab-
dominal fat depot may induce a low-grade inflammatory
state (46, 47), which in turn will stimulate lipid peroxida-
tion (48). This increased lipid peroxidation could then
promote DNA damage, which has been shown to contrib-
ute to vascular dysfunction (49). Moreover, vascular dys-
function may also result directly from visceral obesity in-
dependently of other conventional risk factors (50).
A most important finding is the fact that all these associ-
ations were observed among subjects who would have
been considered normal by the commonly used anthropo-
metrical risk factors. This is consistent with the dramatic
increases in CVD rates observed in Korea in the absence
of significant BMI increases, supporting the greater rele-
vance of fat distribution. Therefore, the major goal of in-
tervention studies should be the reduction of visceral fat
through physical exercise and heart-healthy nutrition
guidelines even for those subjects who are considered at
low risk based on their BMI values. Moreover, similar stud-
ies are needed on White subjects to investigate the gener-
ality of our findings.
This study was partly supported by the Ministry of Health and
Welfare, Korea; Food Ingredient Division, Foods R&D Center,
CJ Corp., Seoul, Korea; Grants from NIH/NHLBI #HL54776;
and contracts 53-K06-5-10 and 58-1950-9-001 from the US De-
partment of Agriculture Research Service.
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